| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 113 |
| 1 | ADALIMUMAB | 111 |
| 2 | ETANERCEPT | 106 |
| 3 | TOCILIZUMAB | 106 |
| 4 | LEFLUNOMIDE | 105 |
| 5 | ABATACEPT | 104 |
| 6 | INFLIXIMAB | 103 |
| 7 | SULFASALAZINE | 103 |
| 8 | METHOTREXATE | 101 |
| 9 | RITUXIMAB | 98 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIMENHYDRINATE | 43 | 0.0040 |
| 1 | EMPAGLIFLOZIN AND LINAGLIPTIN | 7 | 0.0036 |
| 2 | ALEMTUZUMAB | 63 | 0.0033 |
| 3 | DEFLAZACORT | 8 | 0.0031 |
| 4 | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | 2 | 0.0031 |
| 5 | DICLOFENAC POTASSIUM | 28 | 0.0025 |
| 6 | CORTISOL | 1 | 0.0025 |
| 7 | CALCIUM GLUCONATE | 28 | 0.0023 |
| 8 | BARIUM SULFATE | 1 | 0.0023 |
| 9 | CORTISONE ACETATE | 28 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 112 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 111 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 106 |
| 3 | Antirheumatic Agent [EPC] | 105 |
| 4 | Corticosteroid [EPC] | 105 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 104 |
| 6 | Aminosalicylate [EPC] | 103 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 103 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 101 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 63 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 63 | 0.0033 |
| 1 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 2 | Aminosalicylate [EPC] | 103 | 0.0010 |
| 3 | Antirheumatic Agent [EPC] | 105 | 0.0010 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 106 | 0.0008 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 104 | 0.0007 |
| 6 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 7 | Bismuth [EPC] | 2 | 0.0004 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 103 | 0.0003 |
| 9 | Plasma Volume Expander [EPC] | 1 | 0.0003 |